Diclofenac topical - Futura Medical

Drug Profile

Diclofenac topical - Futura Medical

Alternative Names: TPR 100; TPR 100Rx

Latest Information Update: 16 Jul 2015

Price : $50

At a glance

  • Originator Futura Medical
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Pain
  • No development reported Musculoskeletal pain

Most Recent Events

  • 14 Jul 2015 Futura Medical completes a phase I trial with three topical NSAID products in Pain (volunteers) in United Kingdom
  • 28 Mar 2015 No development reported - Preclinical for Musculoskeletal pain in United Kingdom (Topical) (Futura Medical pipeline, March 2015)
  • 18 Mar 2015 Futura Medical initiates enrolment in a phase I trial for Pain (In volunteers) in United Kingdom
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top